drug candidate investigated help treat cancer chemical formula acts allosteric akt highly selective inhibitor panakt namely three akt isoforms intended used cancer therapies advanced tumours may become resistant phase clinical trial alone reported well phase clinical trial variety agents patients advanced cancer reported acceptable one treatments adaptive clinical trial breast cancer selected later stage august phase ii clinical trials registered many eg colorectal cancer breast cancer many others data shown study preprint suggest infection decreases cellular autophagy induces autophagy reduced virus replication vitro studys authors propose tested clinical trials potential treatment antineoplastic immunomodulatory drug article stub help wikipedia expanding